Market Research Blog

Autoimmune diseases is a body’s hyperactive immune response against the substances and tissues normally present in the body. Autoimmune diseases are more commonly caused by genetic, infectious or environmental factors. The prevalence of autoimmune disease is on rise. According to National Institute of Health, approximately 50 million of Americans suffer from autoimmune diseases. The diseases in estimated to be one of the top 10 cause of death in women under the age 65, and is the second highest cause of chronic illness. Also, it is the top cause of morbidity in women in the U.S. There are more than 80 clinically different type of autoimmune diseases identified till date. Some of the common types of autoimmune diseases are Crohn’s disease, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, systemic lupus erythematosus, and with rising prevalence of autoimmune diseases the demand of drugs used in the treatment for autoimmune disease is also rising.

The global market for autoimmune disease therapeutics is expected to have a robust growth during the forecast period (2016–2026).

Request a free sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-1238

Autoimmune Disease Therapeutics Market: Drivers and Restraints

Factors contributing to the growth of global autoimmune disease therapeutics market includes, growing prevalence of autoimmune diseases coupled with growing public awareness and increasing automation of laboratories leading to diagnosis of several diagnostic tests simultaneously to generate rapid and error free results. In addition, technological advancements such as the development of novel biomarkers such as Enbrel and Humira, and portable diagnostic point of care equipment are further expected to fuel the market growth in the near future. However, factors such as, inadequate funding in developing countries, high cost involved in the treatment of the disease and non-availability of the treatment in developing countries along with emergence of alternative technologies are the main restraints for the global autoimmune disease therapeutics market.

Autoimmune disease therapeutics Market: Overview

With rising incidence of autoimmune diseases, rapid technological advancements in medical field such as novel biomarkers, rise in healthcare expenditure, development and presence of large untapped opportunities in the emerging markets such as Eastern European, APAC and MEA region are major factors, expected to boost the growth of the global autoimmune disease therapeutics market during the forecast period (2016–2026).

Autoimmune Disease Therapeutics Market: Region-wise Outlook     

The global market for autoimmune disease therapeutics is expected to register a healthy CAGR during the forecast period. Depending on geographic regions, global autoimmune disease therapeutics market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa.

Discover more about report analysis with figures and data tables, along with the table of contents. Request for TOC- https://www.futuremarketinsights.com/toc/rep-gb-1238

North America accounts for the largest market shares in the autoimmune disease therapeutics market owing to growing prevalence of various forms of autoimmune disorders, and presence of government initiatives such as Affordable Care Act and Patient Protection Act.  Increasing healthcare expenditure in the region is also expected to drive the overall autoimmune disease therapeutics market in the near future. According to National Institute of Health estimates in the U.S. the annual expenditure on autoimmune disease therapeutics is estimated to be US$ 100 Bn. Europe is anticipated to be the second largest market during the forecast period owing to increasing government with the focus of improving healthcare infrastructure, growing prevalence of autoimmune diseases, increased penetration of new technologies such as portable diagnostic equipment and novel biomarkers. However, in Eastern Europe presence of large untapped opportunities will fuel the market growth of autoimmune disease therapeutics in the coming years.

Some of the key market players in global autoimmune disease therapeutics market are Abbott Laboratories, Amgen Inc., Genentech Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer Schering Pharma AG, Johnson & Johnson Inc., Biogen Idec Inc., GlaxoSmithKline Plc, Squibb Company, Elan Corporation Plc, Eli Lilly and Company, Chugai Pharmaceutical Co. Ltd.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, N. Africa)

Request for Pre Book of Report: https://www.futuremarketinsights.com/checkout/1238

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Global autoimmune disease therapeutics market is segmented by drug class, distribution channeland geography as following:

Mechanical ventilators replace or assist the respiratory functions of a critically-ill patient who is at the risk of multiple organ failure due to lack of oxygen supply. These medical devices are expensive to manufacturer and prove to be the differentiating factor between life and death. In the light of COVID-19 pandemic, the world is facing a shortage of mechanical ventilators. Leading manufacturers across the globe are escalating the production of ventilators that could potentially save thousands of lives. Key stakeholders are witnessing an unprecedented demand in the event of current outbreak. Several companies in other industries such as aerospace and engineering have come forward to offer assistance and produce this absolutely vital equipment.

For instance, Dyson and Rolls-Royce have volunteered to manufacture mechanical ventilators in the United Kingdom. Biomedical engineering experts have predicted the scarcity of mechanical ventilators at the peak of COVID-19 pandemic. This has prompted entrepreneurs from wide spectrum of industries to collaborate and ramp up the production of ventilators. Moreover, heavy government incentive to scale up the overall production is another contributing factor. The World Health Organization has repeatedly stressed on the need to optimize the production of lung ventilation equipment. The officials in Germany and the United States have desperately called for new ventilators as well.

Request a free sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-1971

China Accelerates Export of Mechanical Ventilators to Affected Nations

Until February, when Wuhan was the epicentre of COVID-19 outbreak, China escalated its export channels and turned to other nations for assistance. The subsequent month of March witnessed the shift of epicentre from Wuhan, China to Italy in Europe. As the number of new COVID-19 cases and deaths continue to decline in the original epicentre, China has offered help to various affected nations, particularly Italy which has been worst hit by the pandemic. Chinese Red Cross has transported thousands of masks, hundreds of pulmonary ventilators and tons of other medical supply to Italy. The United States now has more COVID-19 patients than any other country. Hence, demand for high flow ventilators is set to accelerate in the foreseeable future.

Manufacturers Undertake Innovative Measures to Combat Ventilator Shortage

Leaders worldwide continue to explore new ways of boosting the production of ventilators. As many nations have banned the export of this life-saving equipment in order to protect their citizens, companies are channelling their resources towards research and development. For instance, in Italy, certain manufacturers are opting for 3D printing technology to expedite the fabrication of mechanical ventilators. Prominent manufacturers in the UK and US have been urged by governments to step-up the production of ventilators. COVID-19 has already overwhelmed the intensive care units of countries such as Italy. The absence of drastic interventions such as shortage of ventilators can have devastating outcomes in other countries as well.

The snorkelling masks originally designed for recreational purposes at the beach are now being utilized by doctors in Italy for treating COVID-19 patients. In severe cases, COVID-19 causes the lungs to undergo fibrosis-like condition because of which the patients are unable to breathe without assistance. Hence, leading innovators are producing ventilators at breakneck speed to bridge the enormous gap between demand and supply. Companies continue to repurpose their supply chains and production lines in the wake of ongoing outbreak. James Dyson has pledged to donate 5000 ventilators to other countries as well. In addition, GE Healthcare announced collaborations with Ford Motor Company to aid ventilator production.

Discover more about report analysis with figures and data tables, along with the table of contents. Request for TOC- https://www.futuremarketinsights.com/toc/rep-gb-1971

Insights into Global Ventilator Market: Key Regions, Drivers and Players

The global ventilator market is set to represent a billion-dollar industry on account of greater prevalence of respiratory diseases such as pneumonia, and COVID-19. In view of the widespread coronavirus outbreak, leading companies continue to expand their capacities to meet the unprecedented demand spurred by COVID-19. Some of the major players in the global ventilator market include, but are not limited to, Medtronic, Dickinson and Company, Becton, Getinge, Hamilton Medical, GE Healthcare, Allied Healthcare Products, Resmed, Smiths Group, Air Liquide, Asahi Kasei, and Fisher & Paykel. Medtronic recently announced that its production facilities will be operational 24/7 to fulfil the soaring demand for ventilators. The company has scaled up its production capacity and doubled its workforce to produce new ventilators.

The growth of global ventilator market is supported by emergency relief packages approved by governments across the globe. Further, greater healthcare expenditure, developed healthcare infrastructure in countries such as the United States and Canada are complementing the growth of ventilator market. On the other hand, Asia Pacific ventilator market will benefit owing to the presence of a large geriatric population, particularly in countries such as Japan and South Korea. Moreover, India remains the largest importer of life-saving medical devices such as ventilators which will offer lucrative opportunities for manufacturers in the months to come.

Global Ventilator Market: Overview of Segmentation

The segmental analysis of the global ventilator market is performed on the basis of end use (ambulatory care centres, emergency medical services, hospitals & clinics), mode (combined-mode, volume-mode, and pressure-mode), type (neonatal/infant ventilators, paediatric/adult ventilators), and mobility (intensive care ventilators, critical care, and portable ventilators) across five regions (North America, Latin America, Europe, Middle East & Africa, Asia Pacific). Hospitals remain the leading end-use segment of ventilators. Demand for ventilators is witnessing an upswing in almost every major continent of the world. Critical cases of COVID-19 are quite rare among children. Therefore, adult ventilators will witness relatively greater demand worldwide. The market leaders must focus on developing portable, cost-effective, and patient-friendly ventilators to encourage its usage.

Rising population, urbanization, and chronic respiratory diseases such asthma are key drivers of ventilators market. Moreover, other lifestyle factors such as smoking are major contributors to the demand for ventilators. As COVID-19 sweeps the globe, the scarcity of mechanical ventilators will be excruciating for frontline staff to save precious lives. Hence, global manufacturers face the daunting task of meeting enormous demand and searching for new innovations to combat this deadly respiratory illness. Governments’ relief packages, major collaborations, and innovations in ventilators market have the potential to save countless lives in the foreseeable future.

Request for Pre Book of Report: https://www.futuremarketinsights.com/checkout/1971

Key opinion leaders (KOLs) are influential, trustworthy thought leaders who are held in high esteem. In the current scenario of the healthcare industry, an organization’s success is related to its ability to build, maintain, and manage relationships with KOLs. KOLs play a crucial role in educating the medical and scientific communities and in building awareness regarding the latest key developments in medical technology. A KOL dashboard is used for identification and monitoring a KOL. KOLs play an important role in the complex and competitive scenario of companies, especially in healthcare marketing. KOLs help in influencing the perception and opinion of various stakeholders in a company.

Key Opinion Leader Management Market:  Drivers & Restraints

KOL has emerged as an individual business discipline which is similar to CRM. KOL management is an essential component in marketing. Companies experience an increased influence and adoption at the global, national, and regional levels, by managing KOL relationships effectively for the future of company products and market expansion. The most prominent KOLs are usually expensive. KOL management in healthcare is challenging.  Leading KOL physicians are frequently over-marketed to by many sources. Laws such as the Sunshine Act demand transparency and restrict large payments to physician KOLs. KOLs help in critical decisions such as drug prescriptions for their patients, as the KOL physicians advice on specific drugs based on their knowledge.

Request a free sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-1660

Key Opinion Leader Management Market:  Overview

KOL management gives a 360-degree view of KOL influence and activity, alongwith the ability to see what KOLs are saying about their products and their competitor products.  KOL performance can also be monitored regularly to check how an influencer aids in product sales, and spending of a KOL. KOLs play an important role for several companies particularly, pharmaceutical companies. A reliable KOL management process, provides benefits such as the ability to reduce cycle time for widening a pool of KOLs, understanding and tracking of campaign effectiveness conducted by an individual KOL, differentiate KOLs based on their influence to alter strategic decisions related to spending and so on.

Key Opinion Leader Management Market: Region wise Overview

Geographically, global key opinion leader management market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, Middle East and Africa (MEA).KOL management involves KOL identification process, ranking methodology, and ability to combine traditional and social footprints of influencers across therapeutic areas, regions and languages. The expenditure on shaping influence is high. Companies need to understand influence as it is a potential marketing tool. KOLs possess a unique credibility, as their validity is important due to years of industry experience and medical affiliations. As a result, healthcare companies particularly in the developed countries of North America and Western Europe have begun relying heavily on KOLs to help establish the knowledge base about their drugs and expand their markets throughout all stages of life-cycle management.

Discover more about report analysis with figures and data tables, along with the table of contents. Request for TOC- https://www.futuremarketinsights.com/toc/rep-gb-1660

Key Opinion Leader Management Market: Key Players

The key players in global key opinion leader management market are Genpact Limited, KOL, LLC, SAAMA TECHNOLOGIES, Cognizant, RELTIO to name a few.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, accessories and applications.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Brazil, Rest Of Latin America)
• Western Europe (Germany, Italy, France, U.K, Spain, Rest Of Western Europe)
• Eastern Europe (Russia, Rest Of Eastern Europe)
•  Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC countries, S. Africa and Rest Of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request for Pre Book of Report: https://www.futuremarketinsights.com/checkout/1660

The global key opinion leader management market is classified on the basis of therapeutic area, region.

An allergy is a heightened sensitivity of immune system.  Allergy occurs when a foreign substance which is harmless in nature reacts with immune system. These foreign substances are called allergens. Some of the allergens that affect the immune system are dust mite, animal dander, cockroach, pollens and mold. Dust mite, animal dander and mold can cause indoor allergy problems. Allergy can be of various types such as eye allergy, Rhinitis, asthma, skin allergy, etc. According to the World Allergy Organization, approximately 30-40% of the world population was affected by allergic condition in 2011. Severe allergy can be life threatening in some patients as allergy severity reduces the function of organs such as allergic asthma causes the poor lungs function.

Allergy Treatment Market: Drivers and Restraints

Globally, increasing patient population with various type of allergies, changing life style and environment pollution is increasing, which drives the global allergy treatment market. Increasing number of patients with various allergies such as skin allergy, eye allergy, Rhinitis, asthma, etc., changes in dietary habits, rising demand for advanced therapy for allergy treatment, increasing research and development activities, government initiative, are some of the factors that drive the growth of the global allergy treatment market. However, high cost of immunotherapy for allergy treatment and side effects from immunotherapy act as a restraint in the global allergy treatment market.

Request a free sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-1342

Allergy Treatment Market: Overview

Allergic diseases occur due to hypersensitivity of the immune system towards environment that usually causes minute problems in most individuals. These allergic diseases includes food allergy, allergic asthma, hay fever, atopic dermatitis and anaphylaxis. Symptoms for these allergic diseases are runny nose, an itchy rash, shortness of breath, red eyes, swelling and some more. Such allergies are treated by avoiding known allergens, immunotherapy and by the use of medications such as antihistamines and steroids. In industrialized countries, allergic diseases are more common as compared to the countries that are more agricultural or traditional and it is noticed that there is a lower rate of allergic disease in rural populations versus urban populations.

Allergy Treatment Market: Region- wise Outlook

Depending on geographic regions, global allergy treatment market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan and Middle East & Africa. North America followed by Europedominates the global allergy treatment market due to increasing number of patients with various type of allergies including respiratory allergy, skin allergy, eye allergy, etc. growing environmental pollution, developed healthcare infrastructure and growing demand for immunotherapy for treatment of allergies in these region. Asia-Pacific is the fastest emerging market for global allergy treatment due to growing allergic patient population, increasing awareness about advanced immunotherapy for treatment of allergies available in the market, developing healthcare infrastructure and rising government spending in healthcare industry in this region.

Discover more about report analysis with figures and data tables, along with the table of contents. Request for TOC- https://www.futuremarketinsights.com/toc/rep-gb-1342

Allergy Treatment Market: Key Players

Some of the key market players in global allergy treatment market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc. and Vicks. Currently, the companies which operate in allergy treatment, are entering into mergers and acquisition with other companies to expand its allergy treatment business. For instance, in June 2015, Allergy Therapeutics acquired Alerpharma S.A, a Spanish company develops and now offers allergy immunotherapy products and services to expand its allergy immunotherapy business. In addition, In November 2015, Pfizer Inc., a multinational pharmaceutical corporation entered into a merger with Allergan PLC, a pharmaceutical company to capture more market share in the drug industry.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and applications.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes:

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands)
• Eastern Europe (Poland, Russia)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request for Pre Book of Report: https://www.futuremarketinsights.com/checkout/1342